These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 21054466

  • 1. Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: a case report and literature review.
    Hsiao SH, Chen HH, Chou CH, Lin WL, Liu Yeh PY, Wu TJ.
    J Clin Pharm Ther; 2010 Dec; 35(6):729-32. PubMed ID: 21054466
    [Abstract] [Full Text] [Related]

  • 2. Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin.
    Hsiao SH, Chang CM, Tsai JC, Lin CY, Liao LH, Lin WL, Wu TJ.
    Ann Pharmacother; 2007 May; 41(5):891-4. PubMed ID: 17426073
    [Abstract] [Full Text] [Related]

  • 3. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
    Hung YP, Lee NY, Chang CM, Lee HC, Wu CJ, Chen PL, Lee CC, Chung CH, Ko WC.
    Clin Ther; 2009 Sep; 31(9):1977-86. PubMed ID: 19843487
    [Abstract] [Full Text] [Related]

  • 4. High risk of cross-reactivity between vancomycin and sequential teicoplanin therapy.
    Hsiao SH, Chou CH, Lin WL, Lee EJ, Liao LH, Chang HJ, Yeh PY, Lin CY, Wu TJ.
    J Clin Pharm Ther; 2012 Jun; 37(3):296-300. PubMed ID: 22017186
    [Abstract] [Full Text] [Related]

  • 5. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
    Hahn-Ast C, Glasmacher A, Arns A, Mühling A, Orlopp K, Marklein G, Von Lilienfeld-Toal M.
    Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
    [Abstract] [Full Text] [Related]

  • 6. Vancomycin-induced neutropenia resolves after substitution with teicoplanin.
    Sanche SE, Dust WN, Shevchuk YM.
    Clin Infect Dis; 2000 Sep; 31(3):824-5. PubMed ID: 11017842
    [Abstract] [Full Text] [Related]

  • 7. Probable vancomycin-induced neutropenia.
    Segarra-Newnham M, Tagoff SS.
    Ann Pharmacother; 2004 Nov; 38(11):1855-9. PubMed ID: 15466904
    [Abstract] [Full Text] [Related]

  • 8. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L, Encinas MP, Morín LS, Vilches P, Gutiérrez N, García-Sanz R, Caballero D, Hurlé AD.
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [Abstract] [Full Text] [Related]

  • 9. Comparative safety of teicoplanin and vancomycin.
    Wilson AP.
    Int J Antimicrob Agents; 1998 May; 10(2):143-52. PubMed ID: 9716291
    [Abstract] [Full Text] [Related]

  • 10. A case of hypersensitivity syndrome to both vancomycin and teicoplanin.
    Kwon HS, Chang YS, Jeong YY, Lee SM, Song WJ, Kim HB, Kim YK, Cho SH, Kim YY, Min KU.
    J Korean Med Sci; 2006 Dec; 21(6):1108-10. PubMed ID: 17179696
    [Abstract] [Full Text] [Related]

  • 11. Comparative safety of teicoplanin and vancomycin.
    Wood MJ.
    J Chemother; 2000 Nov; 12 Suppl 5():21-5. PubMed ID: 11131960
    [Abstract] [Full Text] [Related]

  • 12. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
    Figuera A, Tomás JF, Hernández L, Jiménez ML, Peñarrubia MJ, del Rey MC, Arranz R, Cámara R, López-Lorenzo JL, Fernández-Rañada JM.
    Rev Clin Esp; 1996 Aug; 196(8):515-22. PubMed ID: 8984537
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation.
    Kato-Hayashi H, Niwa T, Ohata K, Harada S, Matsumoto T, Kitagawa J, Tsurumi H, Suzuki A.
    J Clin Pharm Ther; 2019 Dec; 44(6):888-894. PubMed ID: 31373043
    [Abstract] [Full Text] [Related]

  • 14. Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure.
    Duff JM, Moreb JS, Muwalla F.
    Ann Pharmacother; 2012 Jan; 46(1):e1. PubMed ID: 22170976
    [Abstract] [Full Text] [Related]

  • 15. Glycopeptide-induced vasculitis--cross-reactivity between vancomycin and teicoplanin.
    Marshall C, Street A, Galbraith K.
    J Infect; 1998 Jul; 37(1):82-3. PubMed ID: 9733391
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Teicoplanin-induced neutropenic sepsis mimicking endocarditis.
    Booth K, Parissis H.
    Asian Cardiovasc Thorac Ann; 2012 Aug; 20(4):460-2. PubMed ID: 22879557
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. DRESS Syndrome Caused by Cross-reactivity Between Vancomycin and Subsequent Teicoplanin Administration: A Case Report.
    Miyazu D, Kodama N, Yamashita D, Tanaka H, Inoue S, Imakyure O, Hirakawa M, Shuto H, Kataoka Y.
    Am J Case Rep; 2016 Aug 30; 17():625-31. PubMed ID: 27572807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.